Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'monoamine oxidase inhibitor' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 136 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cacchi, S; Fabrizi, G; Goggiamani, A; Zappia, G
      3-aryl-2-oxazolidinones through the palladium-catalyzed N-arylation of 2-oxazolidinones

      ORGANIC LETTERS
    2. Borsini, F; Brambilla, A; Cesana, R; Grippa, N
      Lack of interaction between flibanserin and antidepressants in inducing serotonergic syndrome in rats

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    3. Hoskins, JM; Gross, AS; Shenfield, GM; Rivory, LP
      High-performance liquid chromatography-electrospray ionization mass spectrometry method for the measurement of moclobemide and two metabolites in plasma

      JOURNAL OF CHROMATOGRAPHY B
    4. Coupland, NJ; Bell, C; Potokar, JP; Bailey, JE; Nutt, DJ
      Cardiovascular reflexes during treatment of social phobia with moclobemide

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    5. Prueter, C; Schiefer, J; Norra, C; Podoll, K; Sass, H
      Ping-pong gaze in combined intoxication with tranylcypromine, thioridazine, and clomipramine

      NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY
    6. Landolt, HP; de Boer, LP
      Effect of chronic phenelzine treatment on REM sleep: Report of three patients

      NEUROPSYCHOPHARMACOLOGY
    7. Connor, KM; Hidalgo, RB; Crockett, B; Malik, M; Katz, RJ; Davidson, JRT
      Predictors of treatment response in patients with posttraumatic stress disorder

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    8. Han, YN; Choo, Y; Lee, YC; Moon, YI; Kim, SD; Choi, JW
      Monoamine oxidase B inhibitors from the fruits of Opuntia ficus-indica var. saboten

      ARCHIVES OF PHARMACAL RESEARCH
    9. Kretzschmar, M
      Undesirable interactions of anaesthetics with other agents - drug interactions in anaesthesia

      ANASTHESIOLOGIE & INTENSIVMEDIZIN
    10. Levant, B; Morgan, KA; Ahlgren-Beckendorf, JA; Grandy, DK; Chen, K; Shih, JC; Seif, I
      Modulation of [H-3]quinpirole binding at striatal D-2 dopamine receptors by a monoamine oxidase(A)-like site - Evidence from radioligand binding studies and D-2 receptor- and MAO(A)-deficient mice

      LIFE SCIENCES
    11. Usami, N; Kitahara, K; Ishikura, S; Nagano, M; Sakai, S; Hara, A
      Characterization of a major form of human isatin reductase and the reducedmetabolite

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    12. Yadid, G; Overstreet, DH; Zangen, A
      Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression

      BRAIN RESEARCH
    13. Mawatari, K; Segawa, M; Masatsuka, R; Hanawa, Y; Iinuma, F; Watanabe, M
      Fluorimetric determination of isatin in human urine and serum by liquid chromatography postcolumn photoirradiation

      ANALYST
    14. Davidson, JRT
      Social anxiety disorder under scrutiny

      DEPRESSION AND ANXIETY
    15. Hamaue, N; Yamazaki, N; Terado, M; Minami, M; Ohno, K; Ide, H; Ogata, A; Honma, S; Tashiro, K
      Urinary isatin concentrations in patients with Parkinson's disease determined by a newly developed HPLC-LTV method

      RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
    16. Kato, M; Iwata, H; Okamoto, M; Ishii, T; Narita, H
      Focal cerebral ischemia-induced escape deficit in rats is ameliorated by areversible inhibitor of monoamine oxidase-A: Implications for a novel animal model of post-stroke depression

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    17. Ogawa, N
      Factors affecting levodopa effects in Parkinson's disease

      ACTA MEDICA OKAYAMA
    18. Gareri, P; Falconi, U; De Fazio, P; De Sarro, G
      Conventional and new antidepressant drugs in the elderly

      PROGRESS IN NEUROBIOLOGY
    19. Hamaue, N
      Pharmacological role of isatin, an endogenous MAO inhibitor

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    20. Maki, Y; Inoue, T; Izumi, T; Muraki, I; Ito, K; Kitaichi, Y; Li, XB; Koyama, T
      Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    21. Gilliland, SL; Alper, RH; Levant, B
      Pharmacology of quinpirole-stimulated [S-35]GTP gamma S binding: discrepancy with receptor binding profile

      EUROPEAN JOURNAL OF PHARMACOLOGY
    22. Lacan, G; Satyamurthy, N; Barrio, JR
      Synthesis of stereo (R and S) and geometric (E and Z) isomers of [F-18]fluoro-beta-fluoromethylene-m-tyrosine derivatives: In vivo probes of central dopaminergic function

      NUCLEAR MEDICINE AND BIOLOGY
    23. Huang, SC; Quintana, J; Satyamurthy, N; Lacan, G; Yu, DC; Phelps, ME; Barrio, JR
      [F-18]fluoro-beta-fluoromethylene-m-tyrosine derivatives show stereo, geometrical, and regio specificities as in vivo central dopaminergic probes in monkeys

      NUCLEAR MEDICINE AND BIOLOGY
    24. Josey, ES; Tackett, RL
      St. John's wort: a new alternative for depression?

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    25. Newton, TF; Kalechstein, A; Beckson, M; Bartzokis, G; Bridge, TP; Ling, W
      Effects of selegiline pretreatment on response to experimental cocaine administration

      PSYCHIATRY RESEARCH
    26. HORI A
      PHARMACOTHERAPY FOR PERSONALITY-DISORDERS

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    27. DALVI A; FORD B
      ANTIPARKINSONIAN AGENTS - CLINICALLY SIGNIFICANT DRUG-INTERACTIONS AND ADVERSE-EFFECTS, AND THEIR MANAGEMENT

      CNS DRUGS
    28. GILLMAN PK
      SEROTONIN SYNDROME - HISTORY AND RISK

      Fundamental and clinical pharmacology
    29. HAMAUE N; YAMAZAKI N; MINAMI M; ENDO T; HIRAHUJI M; MONMA Y; TOGASHI H
      DETERMINATION OF ISATIN, AN ENDOGENOUS MONOAMINE-OXIDASE INHIBITOR, IN URINE AND TISSUES OF RATS BY HPLC

      General pharmacology
    30. HUCKLEBRIDGE F; DOYLE A; PANG FY; ADLARD M; EVANS P; CLOW A
      REGIONAL AND MOLECULAR SEPARATION OF THE 4 BIOACTIVITIES OF TRIBULIN

      Neuroscience letters
    31. OXENKRUG GF; REQUINTINA PJ
      THE EFFECT OF MAO-A INHIBITION AND COLD-IMMOBILIZATION STRESS ON N-ACETYLSEROTONIN AND MELATONIN IN SHR AND WKY RATS

      Journal of neural transmission. Supplementum
    32. NATELSON BH; CHEU J; HILL N; BERGEN M; KORN L; DENNY T; DAHL K
      SINGLE-BLIND, PLACEBO PHASE-IN TRIAL OF 2 ESCALATING DOSES OF SELEGILINE IN THE CHRONIC-FATIGUE-SYNDROME

      Neuropsychobiology
    33. TAKADA Y; NAGAI N; TAKAHASHI H; URANO T; TAKADA A
      INCREASED SEROTONERGIC ACTIVITIES INHIBIT FEEDINGS AND CAUSE AROUSAL RESPONSES IN RATS

      Biogenic amines
    34. JOUVENT R; LEHOUEZEC J; PAYAN C; MIKKELSEN H; FERMANIAN J; MILLET V; DUFOUR H
      DIMENSIONAL ASSESSMENT OF ONSET OF ACTION OF ANTIDEPRESSANTS - A COMPARATIVE-STUDY OF MOCLOBEMIDE VS CLOMIPRAMINE IN DEPRESSED-PATIENTS WITH BLUNTED AFFECT AND PSYCHOMOTOR RETARDATION

      Psychiatry research
    35. Curet, O; Damoiseau-Ovens, G; Sauvage, C; Sontag, N; Avenet, P; Depoortere, H; Caille, D; Bergis, O; Scatton, B
      Preclinical profile of befloxatone, a new reversible MAO-A inhibitor

      JOURNAL OF AFFECTIVE DISORDERS
    36. Rosenzweig, P; Patat, A; Curet, O; Durrieu, G; Dubruc, C; Zieleniuk, I; Legangneux, E
      Clinical pharmacology of befloxatone: a brief review

      JOURNAL OF AFFECTIVE DISORDERS
    37. HEINONEN EH; MYLLYLA V
      SAFETY OF SELEGILINE (DEPRENYL) IN THE TREATMENT OF PARKINSONS-DISEASE

      Drug safety
    38. WARD HE; JOHNSON EA; GOODMAN IJ; BIRKLE DL; COTTRELL DJ; AZZARO AJ
      CORTICOTROPIN-RELEASING FACTOR AND DEFENSIVE WITHDRAWAL - INHIBITION OF MONOAMINE-OXIDASE PREVENTS HABITUATION TO CHRONIC STRESS

      Pharmacology, biochemistry and behavior
    39. LEVANT B; BANCROFT GN
      INHIBITION OF [H-3]QUINPIROLE BINDING BY A MONOAMINE-OXIDASE INHIBITOR IN SUBCELLULAR-FRACTIONS OF RAT STRIATUM

      Life sciences (1973)
    40. FUJIMOTO H; SATOH Y; YAMAGUCHI K; YAMAZAKI M
      MONOAMINE-OXIDASE INHIBITORY CONSTITUENTS FROM ANIXIELLA-MICROPERTUSA

      Chemical and Pharmaceutical Bulletin
    41. CHAIRUNGSRILERD N; FURUKAWA K; TADANO T; KISARA K; OHIZUMI Y
      EFFECT OF GAMMA-MANGOSTIN THROUGH THE INHIBITION OF 5-HYDROXY-TRYPTAMINE(2A) RECEPTORS IN 5-FLUORO-ALPHA-METHYLTRYPTAMINE-INDUCED HEAD-TWITCH RESPONSES OF MICE

      British Journal of Pharmacology
    42. TOZAWA Y; UEKI A; MANABE S; MATSUSHIMA K
      STRESS-INDUCED INCREASE IN URINARY ISATIN EXCRETION IN RATS - REVERSAL BY BOTH DEXAMETHASONE AND ALPHA-METHYL-P-TYROSINE

      Biochemical pharmacology
    43. NOWAKOWSKA E; CHODERA A; KUS K; RYBAKOWSKI J
      ANXIOLYTIC AND MEMORY IMPROVING EFFECTS OF MOCLOBEMIDE

      Arzneimittel-Forschung
    44. MANABE S; GAO Q; YUAN J; TAKAHASHI T; UEKI A
      DETERMINATION OF ISATIN IN URINE AND PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical sciences and applications
    45. BRUHWYLER J; LIEGEOIS JF; GECZY J
      PIRLINDOLE - A SELECTIVE REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE-A - A REVIEW OF ITS PRECLINICAL PROPERTIES

      Pharmacological research
    46. HODGMAN MJ; MARTIN TG; KRENZELOK EP
      SEROTONIN SYNDROME DUE TO VENLAFAXINE AND MAINTENANCE TRANYLCYPROMINETHERAPY

      Human & experimental toxicology
    47. KATO M; IWATA H; KATAYAMA T; ASAI H; NARITA H; ENDO T
      POSSIBLE THERAPEUTIC EFFECT OF T-794, A NOVEL REVERSIBLE INHIBITOR OFMONOAMINE OXIDASE-A, ON POSTSTROKE EMOTIONAL DISTURBANCES, ASSESSED IN ANIMAL-MODELS OF DEPRESSION

      Biological & pharmaceutical bulletin
    48. OBATA T; INADA T; YAMANAKA Y
      INTRACRANIAL MICRODIALYSIS OF SALICYLIC-ACID TO DETECT HYDROXYL RADICAL GENERATION BY ANTIDEPRESSANT DRUGS IN THE RAT

      Neuroscience research communications
    49. DEWILDE J; MERTENS C; VANDORPE J; BRUHWYLER J; GECZY J
      DOUBLE-BLIND RANDOMIZED CONTROLLED PILOT-STUDY OF THE EFFICACY AND TOLERABILITY OF PIRLINDOLE, A REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE-A, AND MIANSERIN, IN THE TREATMENT OF DEPRESSION

      Human psychopharmacology
    50. BURROWS GD; NORMAN T
      ANTIDEPRESSANTS - CLINICAL ASPECTS

      Stress medicine
    51. DUNCAN WC; JOHNSON KA; WEHR TA
      INCREASE OF 5HT AND VIP IMMUNOREACTIVITY WITHIN THE HAMSTER (MESOCRICETUS-AURATUS) SCN DURING CHRONIC MAOI TREATMENT

      Neuroscience letters
    52. GILL HS; DEVANE CL; RISCH SC
      EXTRAPYRAMIDAL SYMPTOMS ASSOCIATED WITH CYCLIC ANTIDEPRESSANT TREATMENT - A REVIEW OF THE LITERATURE AND CONSOLIDATING HYPOTHESES

      Journal of clinical psychopharmacology
    53. JURUENA MF; PIRES MLN; CALIL HM
      MOCLOBEMIDE EFFECTS ON PROLACTIN PLASMA-LEVELS IN HEALTHY-INDIVIDUALS- THE HORMONAL INCREASE INDUCED BY A SINGLE-DOSE IS MAINTAINED DURINGA 4-WEEK PERIOD OF DRUG INTAKE

      International clinical psychopharmacology
    54. VERSIANI M; AMREIN R; STABL M; MAGISTRIS; UDABE RU; DACOSTA DA; NARDI AE; CAPPONI R
      MOCLOBEMIDE AND IMIPRAMINE IN CHRONIC DEPRESSION (DYSTHYMIA) - AN INTERNATIONAL DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

      International clinical psychopharmacology
    55. IWATA N; PUCHLER K; PLENKER A
      PHARMACOLOGY OF THE NEW REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE-A, RS-8359

      International clinical psychopharmacology
    56. PUCHLER K; SASAHARA K; PLENKER A; NITANAI T; WITTE PU
      THE PHARMACOKINETIC PROFILE OF RS-8359

      International clinical psychopharmacology
    57. PUCHLER K; SCHAFFLER K; PLENKER A
      THE COMPARATIVE EFFECTS OF SINGLE AND MULTIPLE DOSES OF RS-8359, MOCLOBEMIDE AND PLACEBO ON PSYCHOMOTOR FUNCTION IN HEALTHY-SUBJECTS

      International clinical psychopharmacology
    58. PLENKER A; PUCHLER K; VOLZ HP
      THE EFFECTS OF RS-8359 ON CARDIOVASCULAR FUNCTION IN HEALTHY-SUBJECTSAND DEPRESSED-PATIENTS

      International clinical psychopharmacology
    59. PUCHLER K; PLENKER A; VOLZ HP
      SAFETY, TOLERABILITY AND EFFICACY OF THE REVERSIBLE MONOAMINE-OXIDASEINHIBITOR RS-8359 IN EARLY CLINICAL-TRIALS

      International clinical psychopharmacology
    60. THIFFAULT C; QUIRION R; POIRIER J
      THE EFFECT OF L-DEPRENYL, D-DEPRENYL AND MDL72974 ON MITOCHONDRIAL RESPIRATION - A POSSIBLE MECHANISM LEADING TO AN ADAPTIVE INCREASE IN SUPEROXIDE-DISMUTASE ACTIVITY

      Molecular brain research
    61. WOUTERS J; OOMS F; DURANT F
      2-OXAZOLIDINONE

      Acta crystallographica. Section C, Crystal structure communications
    62. WOUTERS J
      MOLECULAR-STRUCTURES OF THE FREE-BASE AND HYDROCHLORIDE FORMS OF 7-METHOXY-1-9H-PYRIDO[3,4-B]INDOLE (HARMINE)

      Bulletin des Societes chimiques belges
    63. CAMARIS C; LITTLE D
      A FATALITY DUE TO MOCLOBEMIDE

      Journal of forensic sciences
    64. WOUTERS J; DURANT F; CHAMPAGNE B; ANDRE JM
      ELECTRONIC-PROPERTIES OF FLAVINS - IMPLICATIONS ON THE REACTIVITY ANDABSORPTION PROPERTIES OF FLAVOPROTEINS

      International journal of quantum chemistry
    65. SHARP T; GARTSIDE SE; UMBERS V
      EFFECTS OF COADMINISTRATION OF A MONOAMINE-OXIDASE INHIBITOR AND A 5-HT1A RECEPTOR ANTAGONIST ON 5-HYDROXYTRYPTAMINE CELL FIRING AND RELEASE

      European journal of pharmacology
    66. HUANG CC; TSAI JJ; HSU KS
      L-DEPRENYL (SELEGILINE) LIMITS THE REPETITIVE FIRING OF ACTION-POTENTIALS IN RAT HIPPOCAMPAL CA1 NEURONS VIA A DOPAMINERGIC MECHANISM

      Brain research
    67. TANGHE A; GEERTS S; VANDORPE J; BRICHARD B; BRUHWYLER J; GECZY J
      DOUBLE-BLIND RANDOMIZED CONTROLLED-STUDY OF THE EFFICACY AND TOLERABILITY OF 2 REVERSIBLE MONOAMINE-OXIDASE-A INHIBITORS, PIRLINDOLE AND MOCLOBEMIDE, IN THE TREATMENT OF DEPRESSION

      Acta psychiatrica Scandinavica
    68. OLANOW CW
      DEPRENYL IN THE TREATMENT OF PARKINSONS-DISEASE - CLINICAL EFFECTS AND SPECULATIONS ON MECHANISM OF ACTION

      Journal of neural transmission. Supplementum
    69. JOFFE RT
      TRANYLCYPROMINE IN RECURRENT BRIEF DEPRESSION - 2 CASE-REPORTS

      International clinical psychopharmacology
    70. MARTIN TG
      SEROTONIN SYNDROME

      Annals of emergency medicine
    71. AMSTERDAM JD; HORNIGROHAN M
      TREATMENT ALGORITHMS IN TREATMENT-RESISTANT DEPRESSION

      The Psychiatric clinics of North America
    72. HORNIGROHAN M; WOLKOWITZ OM; AMSTERDAM JD
      NOVEL STRATEGIES FOR TREATMENT-RESISTANT DEPRESSION

      The Psychiatric clinics of North America
    73. WEIZMAN R; LAOR N; SCHUJOVITSKY A; WOLMER L; ABRAMOVITZSCHNAIDER P; FREUDSTEINDAN A; REHAVI M
      PLATELET IMIPRAMINE BINDING IN PATIENTS WITH POSTTRAUMATIC-STRESS-DISORDER BEFORE AND AFTER PHENELZINE TREATMENT

      Psychiatry research
    74. FLINT AJ; RIFAT SL
      THE EFFECT OF SEQUENTIAL ANTIDEPRESSANT TREATMENT ON GERIATRIC DEPRESSION

      Journal of affective disorders
    75. IWERSEN S; SCHMOLDT A
      ONE FATAL AND ONE NONFATAL INTOXICATION WITH TRANYLCYPROMINE - ABSENCE OF AMPHETAMINES AS METABOLITES

      Journal of analytical toxicology
    76. MIURA H; NAOI M; NAKAHARA D; OHTA T; NAGATSU T
      EFFECTS OF MOCLOBEMIDE ON FORCED-SWIMMING STRESS AND BRAIN MONOAMINE LEVELS IN MICE

      Pharmacology, biochemistry and behavior
    77. THASE ME; KUPFER DJ
      RECENT DEVELOPMENTS IN THE PHARMACOTHERAPY OF MOOD DISORDERS

      Journal of consulting and clinical psychology
    78. HEINZ CA; ZANGERL AR; BERENBAUM MR
      EFFECTS OF NATURAL AND SYNTHETIC NEUROACTIVE SUBSTANCES ON THE GROWTHAND FEEDING OF CABBAGE-LOOPER, TRICHOPLUSIA NI

      Entomologia experimentalis et applicata
    79. MUNDEY MK; FLETCHER A; MARSDEN CA
      EFFECTS OF 8-OHDPAT AND 5-HT1A ANTAGONISTS WAY100135 AND WAY100635, ON GUINEA-PIG BEHAVIOR AND DORSAL RAPHE 5-HT NEURON FIRING

      British Journal of Pharmacology
    80. MARINESCO S; PONCET L; DEBILLY G; JOUVET M; CESPUGLIO R
      EFFECTS OF TIANEPTINE, SERTRALINE AND CLOMIPRAMINE ON BRAIN-SEROTONINMETABOLISM - A VOLTAMMETRIC APPROACH IN THE RAT

      Brain research
    81. SACHDEV P; KRUK J
      RESTLESSNESS - THE ANATOMY OF A NEUROPSYCHIATRIC SYMPTOM

      Australian and New Zealand Journal of Psychiatry
    82. DEWILDE JE; GEERTS S; VANDORPE J; BRUHWYLER J; GECZY J
      A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF PIRLINDOLE, A REVERSIBLE MONOAMINE-OXIDASE-A INHIBITOR, INTHE TREATMENT OF DEPRESSION

      Acta psychiatrica Scandinavica
    83. MATSUMOTO RR; HUSSONG MJ; TRUONG DD
      EFFECTS OF SELECTIVE SEROTONERGIC LIGANDS ON POSTHYPOXIC AUDIOGENIC MYOCLONUS

      Movement disorders
    84. CLYBURN EB; DIPETTE DJ
      HYPERTENSION INDUCED BY DRUGS AND OTHER SUBSTANCES

      Seminars in nephrology
    85. ZHU XO; MCNAUGHTON N
      EFFECTS OF LONG-TERM ADMINISTRATION OF PHENELZINE ON RETICULAR-ELICITED HIPPOCAMPAL RHYTHMICAL SLOW ACTIVITY

      Neuroscience research
    86. MARIN DB; BIERER LM; LAWLOR BA; RYAN TM; JACOBSON R; SCHMEIDLER J; MOHS RC; DAVIS KL
      L-DEPRENYL AND PHYSOSTIGMINE FOR THE TREATMENT OF ALZHEIMERS-DISEASE

      Psychiatry research
    87. VOLZ HP; MULLER H; STURM Y; PREUSSLER B; MOLLER HJ
      EFFECT OF INITIAL TREATMENT WITH ANTIDEPRESSANTS AS A PREDICTOR OF OUTCOME AFTER 8 WEEKS

      Psychiatry research
    88. REINISH LW; MACFARLANE JG; SANDOR P; SHAPIRO CM
      REM CHANGES IN NARCOLEPSY WITH SELEGILINE

      Sleep
    89. HSU JH; SHEN WW
      MALE SEXUAL SIDE-EFFECTS ASSOCIATED WITH ANTIDEPRESSANTS - A DESCRIPTIVE CLINICAL-STUDY OF 32 PATIENTS

      International journal of psychiatry in medicine
    90. ABEL EL
      BEHAVIORAL-EFFECTS OF ISATIN ON OPEN-FIELD ACTIVITY AND IMMOBILITY INTHE FORCED SWIM TEST IN RATS

      Physiology & behavior
    91. WU RF; ICHIKAWA Y
      INHIBITION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE METABOLIC-ACTIVITY OF PORCINE FAD-CONTAINING MONOOXYGENASE BY SELECTIVE MONOAMINE OXIDASE-B INHIBITORS

      FEBS letters
    92. MERIKANGAS KR; MERIKANGAS JR
      COMBINATION MONOAMINE-OXIDASE INHIBITOR AND BETA-BLOCKER TREATMENT OFMIGRAINE, WITH ANXIETY AND DEPRESSION

      Biological psychiatry
    93. BREWERTON TD; ZEALBERG JJ; LYDIARD RB; GLOVER V; SANDLER M; BALLENGER JC
      CSF ISATIN IS ELEVATED IN BULIMIA-NERVOSA

      Biological psychiatry
    94. FAHLEN T; NILSSON HL; BORG K; HUMBLE M; PAULI U
      SOCIAL PHOBIA - THE CLINICAL EFFICACY AND TOLERABILITY OF THE MONOAMINE OXIDASE-A AND SEROTONIN UPTAKE INHIBITOR BROFAROMINE - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

      Acta psychiatrica Scandinavica
    95. PAYKEL ES
      CLINICAL EFFICACY OF REVERSIBLE AND SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE-A IN MAJOR DEPRESSION

      Acta psychiatrica Scandinavica
    96. PRIEST RG; GIMBRETT R; ROBERTS W; STEINERT J
      REVERSIBLE AND SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE-A IN MENTAL AND OTHER DISORDERS

      Acta psychiatrica Scandinavica
    97. GREEN AR; CROSS AJ; GOODWIN GM
      REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY)

      Psychopharmacology
    98. FANG J; YU PH; GORROD JW; BOULTON AA
      INHIBITION OF MONOAMINE OXIDASES BY HALOPERIDOL AND ITS METABOLITES -PHARMACOLOGICAL IMPLICATIONS FOR THE CHEMOTHERAPY OF SCHIZOPHRENIA

      Psychopharmacology
    99. DZIUKAS L; CAMERON P
      MANAGEMENT OF ANTIDEPRESSANTS IN OVERDOSE

      CNS DRUGS
    100. TAKAHASHI M; YUASA R; IMAI T; TACHIBANA H; YORIFUJI S; NAKAMURA Y; OGAWA N
      SELEGILINE (L-DEPRENYL) AND L-DOPA TREATMENT OF PARKINSONS-DISEASE - A DOUBLE-BLIND TRIAL

      Internal medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 10:15:15